Related Experiment Video

Updated: Jun 23, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Inflammatory bowel disease reveals the kinase activity of KSR1

Richard Kolesnick1, H Rosie Xing

  • 1Laboratory of Signal Transduction, The Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. r-kolesnick@ski.mskcc.org

The Journal of Clinical Investigation
|November 3, 2004
PubMed

Insights

Kinase suppressor of Ras-1 (KSR1) protects the intestinal lining from cell death during inflammatory bowel disease (IBD). Its kinase activity, previously debated, is crucial for this protective role in IBD.

Area of Science:

  • Cellular biology
  • Molecular signaling pathways
  • Gastroenterology

Background:

  • Kinase suppressor of Ras-1 (KSR1) is implicated in the EGFR-Ras-Raf-1-MAPK pathway.
  • KSR1's intrinsic kinase activity has been a subject of debate.
  • KSR1's role in intestinal epithelium protection requires further elucidation.

Discussion:

  • Polk and colleagues utilized transgenic mouse models and modified colon epithelial cells to investigate KSR1's function.
  • The study reveals KSR1 kinase activity is typically inactive in normal colon cells but activates during inflammatory bowel disease (IBD).
  • Evidence suggests KSR1 kinase activity is vital for protecting the intestinal epithelium against TNF-alpha-induced apoptosis.

Key Insights:

  • KSR1 kinase activity is essential for anti-apoptotic protection of the intestinal epithelium.
  • KSR1 activation is specifically linked to the onset of IBD.
  • The findings provide strong support for KSR1 functioning as an active kinase.

Outlook:

  • Further research is needed to confirm KSR1's role in transphosphorylating and transactivating c-Raf-1 toward MEK1.
  • Understanding KSR1's precise kinase function could lead to new therapeutic strategies for IBD.
  • Investigating the regulatory mechanisms of KSR1 activation in IBD is a key future direction.

More Related Videos

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...